🔴 RISK-OFF Friday, June 26, 2026 5 Setups A+ ⚠ Crisis Mode OFF — Probability Down to 0.215 ⚠ Core PCE Friday — Key Inflation Catalyst ⚠ AAPL −6.1% — Nasdaq Losing Streak Extends

Scanner DailyTickers — Friday, June 26, 2026

Top 5 A+ RISK-OFF — NVS, ING, BUD, XLV, EWJ

RISK-OFF
Regime
83.8
Avg Score
5
Setups
Momentum
Dominant
18.89 (Sub-20, slight uptick from 18.63)
VIX
7,357.49
SPX
🟠 EARLY RISK-OFF — Crisis Mode OFF, International Defensive Pivot — Regime score 28.8, crisis probability 0.215 (below 0.30 threshold → crisis mode deactivated). SPX flat (−0.01%), Nasdaq −0.46% dragged by AAPL −6.1%. Commodities rebounding (gold +0.82%, WTI +1.61%). Japan surging (+4.61%), Europe positive (DAX +1.03%). Strategy: Momentum defensive with international diversification — EU healthcare (NVS), EU banks (ING), consumer staples (BUD), broad healthcare ETF (XLV), APAC exposure (EWJ). 5 picks, R/R ≥ 2.0, Horizon H15. Max pairwise correlation 0.789 (NVS-XLV), avg 0.35.
⚠ Crisis Mode OFF — Probability Down to 0.215: Crisis probability dropped to 0.215 (from 0.359 yesterday), below the 0.30 threshold. Crisis mode deactivated for the first time in 3 sessions. Sizing reverts to standard ERO levels. Regime remains EARLY RISK-OFF (score 28.8 < 40). Portfolio pivots toward international diversification — EU banks, Healthcare, APAC — as the defensive rotation broadens beyond US staples.
⚠ Core PCE Friday — Key Inflation Catalyst: Core PCE Price Index releases Friday June 26, the Fed’s preferred inflation gauge. Hot (>0.3% MoM) = risk-off acceleration. Cool (≤0.2%) = potential regime upgrade toward Neutral. Our defensive positioning benefits either way: cool PCE lifts rate-sensitive financials (ING, NWG), hot PCE reinforces healthcare/staples floor.
⚠ AAPL −6.1% — Nasdaq Losing Streak Extends: Apple plunged 6.1% on MacBook/iPad price hikes driven by memory chip shortage. RSI 33.5 (oversold). Nasdaq extended its losing streak. This validates our zero-tech exposure in ERO. The AAPL crash creates contagion risk for tech-heavy portfolios but reinforces the defensive rotation into healthcare, staples, and yield plays.

Regime score 28.8 — classified EARLY RISK-OFF (per rule regime-score-label-lag: score < 40 = ERO regardless of ensemble label). Ensemble model returned “neutral” but the score override applies. Crisis probability 0.215 (down from 0.359 yesterday) — below 0.30 threshold, crisis mode deactivated. This is the first non-crisis session in 3 days, but the regime remains defensive. SPX essentially flat (−0.01%), VIX 18.89 (sub-20 but above the 16–17 comfort zone). Commodities rebounding from yesterday’s crash (gold +0.82%, WTI +1.61%) suggests the panic selling has subsided. Strategy weights: Momentum 75%, Pre-Squeeze 25% (Breakout blocked per breakout-early-risk-off-block, Pullback blocked per regime-persistence-gate at 3+ consecutive ERO sessions).

Session strategy: The Friday scan broadens the defensive rotation internationally as crisis mode deactivates. Three axes: (1) EU defensive value — NVS (PE 15.6x, div 3.1%) and ING (PE 9.9x, div 4.1%) capture European outperformance (DAX +1.03% vs SPX −0.01%). (2) Consumer staples resilience — BUD near 52W high ($84.86), premiumization thesis intact, beta < 0.5. (3) ETF diversification — XLV (healthcare sector, RSI 63.8) and EWJ (Japan, +4.61% today) provide broad exposure without single-stock risk. Zero tech, zero US single stocks — the AAPL −6.1% crash validates the defensive posture. Core PCE tomorrow is the binary catalyst.

Friday, June 26, 2026

Market Regime: RISK-OFF (Score 0.288)

Regime score 28.8 — classified EARLY RISK-OFF (per rule regime-score-label-lag: score < 40 = ERO regardless of ensemble label). Ensemble model returned “neutral” but the score override applies. Crisis probability 0.215 (down from 0.359 yesterday) — below 0.30 threshold, crisis mode deactivated. This is the first non-crisis session in 3 days, but the regime remains defensive. SPX essentially flat (−0.01%), VIX 18.89 (sub-20 but above the 16–17 comfort zone). Commodities rebounding from yesterday’s crash (gold +0.82%, WTI +1.61%) suggests the panic selling has subsided. Strategy weights: Momentum 75%, Pre-Squeeze 25% (Breakout blocked per breakout-early-risk-off-block, Pullback blocked per regime-persistence-gate at 3+ consecutive ERO sessions).

Market Snapshot (Friday, June 26, 2026)

Index / AssetPriceChangeSignal
S&P 5007,357.49-0.01%Essentially flat 🟡
NASDAQ Composite25,358.60-0.46%AAPL drag, losing streak extends 🔴
Dow Jones51,920.62+0.14%Blue-chips resilient 🟢
Russell 20003,007.86+0.71%Small-caps outperforming 🟢
VIX18.89+1.4%Sub-20 but drifting higher 🟡
DXY (Dollar)101.42-0.18%Dollar softening 🟢
Gold$4,042+0.82%Rebounding from crash 🟢
WTI Crude Oil$71.47+1.61%Bouncing from $69.87 low 🟢
10Y Treasury4.392%-0.01Stable ahead of PCE 🟡
DAX24,994.83+1.03%Europe strong outperformance 🟢
Nikkei 22572,366.34+4.61%Japan surging 🟢

Why go international in EARLY RISK-OFF?

When the US market stalls (SPX −0.01%, Nasdaq losing streak), international diversification isn’t just a nice-to-have — it’s a regime-appropriate strategy. Today the DAX gained +1.03%, the Nikkei surged +4.61%, and EU banks like ING (+0.10%) and NWG (+2.12%) showed resilience. In EARLY RISK-OFF, the playbook is to rotate toward assets that are decorrelated from US tech weakness. European banks benefit from ECB rate normalization and don’t carry AI/chip exposure. Japanese equities benefit from the weak yen and corporate governance reforms. The key principle: geographic diversification reduces portfolio beta to US-centric risks (tariffs, tech regulation, AI capex slowdown) while maintaining exposure to global growth themes.

Visual Overview — 5 Setups

NVS Novartis AG 🇨🇭 ING ING Groep 🇳🇱 BUD Anheuser-Busch InBev 🇧🇪 XLV Health Care 🇺🇸 EWJ iShares MSCI 🇯🇵

Macro Context — Week of Friday, June 26, 2026

Global Events Calendar

DateEventImpactDirection Risk
Fri Jun 26Core PCE Price IndexHIGHFed’s preferred inflation gauge — hot (>0.3%) = risk-off, cool = potential regime upgrade
Fri Jun 26Consumer Sentiment (Michigan Final)MediumConsumption confidence — revision from preliminary
Fri Jun 26Personal Income & SpendingMediumConsumption health ahead of Q3
Mon Jun 30NKE (Nike) Earnings (AMC)MediumConsumer discretionary bellwether
Mon Jun 30Chicago PMIMediumRegional manufacturing health
Tue Jul 1ISM Manufacturing PMIHIGHNational factory health — sub-50 = contraction risk
Wed Jul 2FOMC Minutes (June meeting)HIGHRate path clarity — hawkish surprise = risk-off

Sector Rotation Scorecard

Sector (ETF)Week PerformanceRegime SignalOur Exposure
Healthcare (XLV)+0.3%Steady outperformance continuesNVS #1, XLV #4
Financials (XLF)+0.5%EU banks leading, US flatING #2
Consumer Staples (XLP)+0.2%Defensive rotation intactBUD #3
Technology (XLK)-0.8%AAPL −6.1% drags sector 🔴Zero exposure (ERO discipline)
Energy (XLE)+1.2%Oil rebound +1.61% 🟢Zero exposure
Materials (XLB)+0.4%Recovering from crash 🟡Zero exposure
Utilities (XLU)+0.3%Yield plays stable 🟡No direct exposure

Week-Ahead Thesis

The crisis probability dropping below 0.30 (0.215 vs 0.359 yesterday) signals a subtle shift: the panic is subsiding, but the regime has not upgraded. Three themes drive Friday positioning: (1) International outperformance — the DAX (+1.03%), FTSE (+0.65%), and Nikkei (+4.61%) are all outperforming the SPX (−0.01%). NVS and ING capture the EU premium; EWJ provides APAC exposure to the Japan rally. (2) AAPL contagion containment — Apple’s −6.1% crash on price hikes validates our zero-tech stance. The Nasdaq losing streak could extend if memory chip shortages widen. Our portfolio has zero tech beta. (3) Core PCE binary catalyst — Friday’s Core PCE is the week’s most important data point. Cool inflation lifts rate-sensitive ING and financials, potentially triggering a regime upgrade to Neutral. Hot inflation reinforces the ERO thesis but our healthcare/staples picks (NVS, BUD, XLV) have natural downside floors. Either outcome favors at least part of the portfolio.

#1 NVS — Novartis AG

NVS — Novartis AG

Pharmaceutical / Oncology / Rare Disease • NYSE (ADR) • ~$296B mcap
$155.12
+1.31%
EU (Switzerland) 🇨🇭 Momentum Score 86 EU Healthcare LeaderDiv 3.1% ☪ Halal
NVS FinViz Chart

NVS is the top pick for Friday, combining EU healthcare defensiveness with visible catalysts. PE forward 15.6x offers compelling value vs US pharma peers (LLY 25x, JNJ 19x). Above all EMAs: EMA20 $150.61, EMA50 $150.03, EMA200 $141.95 — clean bullish stack. RSI 60.5 in comfortable momentum zone, extension 2.99% (just under the 3% A+ gate). Dividend 3.1% provides yield floor. Fresh catalyst: $1.9B Antares Therapeutics oncology acquisition announced this week + $5B Pluvicto opportunity highlighted by management. Kisqali + Entresto franchise delivering consistent growth. ATR% 1.86% = low volatility ideal for H15 defensive hold. MACD +1.07 above signal +0.53 confirms bullish momentum. Correlation 0.43 with ING and 0.45 with BUD — well-diversified within the portfolio.

✅ Confirmations

❌ Invalidations

Entry: $154–$156
Stop Loss: $150.50
TP1: $164.00
TP2: $169.00
R/R: 1:2.0
Horizon: 15 days

#2 ING — ING Groep N.V.

ING — ING Groep N.V.

Banking / Financial Services • NYSE (ADR) • ~$89B mcap
$31.02
-0.10%
EU (Netherlands) 🇳🇱 Momentum Score 85 Best Value PE 9.9xDiv 4.1% CONV
ING FinViz Chart

ING offers the deepest value in the scan at PE forward 9.9x with a 4.08% dividend yield — the highest yield of all candidates. The Dutch bank benefits from ECB rate normalization and European economic resilience (DAX +1.03% today). Above all EMAs: EMA20 $30.67, EMA50 $29.86, EMA200 $27.27. RSI 55.9 in early momentum, extension only 1.14% — the lowest in the scan, leaving maximum upside room. MACD 0.455 above signal 0.389 confirms bullish bias. ATR% 2.07% = low volatility for a bank. 52W high $32.22 within reach as TP1 ($33) requires just a 6.4% move. A cool Core PCE would be a direct catalyst for bank stocks via rate expectations. Correlation with NVS 0.43 and with BUD 0.43 — solid diversification.

✅ Confirmations

❌ Invalidations

Entry: $30.50–$31.50
Stop Loss: $30.00
TP1: $33.00
TP2: $34.50
R/R: 1:2.0
Horizon: 15 days

#3 BUD — Anheuser-Busch InBev SA/NV

BUD — Anheuser-Busch InBev SA/NV

Consumer Staples / Beverages • NYSE (ADR) • ~$163B mcap
$84.08
-0.41%
EU (Belgium) 🇧🇪 Momentum Score 84 Near 52W HighConsumer Staples Shield CONV
BUD FinViz Chart

BUD provides consumer staples defensive exposure near its 52-week high ($84.86), just 0.9% away. Above all EMAs: EMA20 $81.55, EMA50 $79.42, EMA200 $72.70 — strong multi-timeframe alignment. PE forward 17.1x is reasonable for the world’s largest brewer. RSI 61.2 in momentum zone, MACD +1.01 above signal +0.83. ATR% 1.86% = low volatility ideal for defensive positioning. The premiumization strategy (shifting mix toward premium brands globally) drives margin expansion. Dividend 1.59%. The stock has been consistently trending higher: from $72.70 (200-DMA) to $84.08 in a clean channel. Extension 3.11% is slightly above the 3% A+ gate — capped at grade A. Correlation with NVS 0.45, with ING 0.43 — complementary diversification.

✅ Confirmations

❌ Invalidations

Entry: $83.50–$84.50
Stop Loss: $81.50
TP1: $89.00
TP2: $91.50
R/R: 1:2.0
Horizon: 15 days

#4 XLV — Health Care Select Sector SPDR

XLV — Health Care Select Sector SPDR

Healthcare ETF / 60+ Holdings • NYSE Arca • AUM $42B+
$155.63
+0.01%
US 🇺🇸 Momentum Score 83 Healthcare Sector ETFLow Vol ATR 1.5% CONV
XLV FinViz Chart

XLV provides broad healthcare sector exposure with minimal single-stock risk (60+ holdings including JNJ, UNH, LLY, MRK, ABT). Above all EMAs: EMA20 $151.49, EMA50 $149.93, EMA200 $146.84. RSI 63.8 in momentum zone. ATR% 1.54% — the lowest volatility in the scan, ideal for defensive H15 positioning. Near 52W high ($160.59), just 3.2% away. Healthcare is the best-performing defensive sector in EARLY RISK-OFF regimes historically. MACD +1.36 above signal +1.29 confirms bullish momentum. As an ETF, XLV eliminates binary pharma pipeline risk (FDA decisions, clinical trial results) while capturing the sector’s defensive premium. Volume >9M shares = optimal liquidity. Correlation with NVS is 0.789 — elevated but under the 0.85 hard threshold.

✅ Confirmations

❌ Invalidations

Entry: $155–$156
Stop Loss: $151.00
TP1: $164.50
TP2: $169.50
R/R: 1:2.0
Horizon: 15 days

#5 EWJ — iShares MSCI Japan ETF

EWJ — iShares MSCI Japan ETF

Japan Equity ETF / 200+ Holdings • NYSE Arca • AUM $15B+
$93.39
+0.01%
APAC (Japan) 🇯🇵 Momentum Score 81 APAC DiversifierNikkei +4.61% CONV
EWJ FinViz Chart

EWJ serves as the APAC geographic diversifier, capturing the Japanese equity rally (Nikkei +4.61% today — the strongest major index move globally). Above all EMAs: EMA20 $93.12, EMA50 $91.44, EMA200 $85.64. RSI 52.9 in neutral-to-bullish zone, extension only 0.29% from EMA20 — near-perfect pullback entry. ATR% 1.86% = low volatility. Japan benefits from structural tailwinds: weak yen boosting exports, Tokyo Stock Exchange governance reforms driving buybacks, and BOJ normalization increasing institutional interest. The Nikkei is trading near all-time highs. EWJ provides decorrelation from US and EU: correlation with NVS 0.24, with ING 0.72 (moderate via EU proxy), with BUD 0.23 — the best portfolio diversifier. 52W high $97.52 within reach as TP1.

✅ Confirmations

❌ Invalidations

Entry: $93–$94
Stop Loss: $90.50
TP1: $99.50
TP2: $103.00
R/R: 1:2.0
Horizon: 15 days

Synthesis — 5 Setup Summary

#TickerNameRegionStrategyScoreEntryStopTP1R/R
1NVSNovartis AGEU (Switzerland)Momentum86$154$150.5$1641:2.0
2INGING Groep N.V.EU (Netherlands)Momentum85$30.5$30$331:2.0
3BUDAnheuser-Busch InBev SA/NVEU (Belgium)Momentum84$83.5$81.5$891:2.0
4XLVHealth Care Select Sector SPDRUSMomentum83$155$151$164.51:2.0
5EWJiShares MSCI Japan ETFAPAC (Japan)Momentum81$93$90.5$99.51:2.0

Sector → Strategy → Setup Flow

Portfolio Parameters & Historical Performance

Performance data will be available after the sweep cycle completes.

How to use these levels

Entry zones are ranges — enter at the open (9:30–9:45 ET) if price falls within range. For EU setups, enter at the London open or early US session ADR price. Stop losses are hard exits, not mental stops. TP1 is the primary profit target: take 50% off at TP1, move stop to breakeven, trail the remainder to TP2. R/R ratios assume entry at the midpoint of the range. Horizon is the expected time to TP1 — if TP1 is not hit within 2× the horizon, reassess.

Methodology

1. Market Regime Detection

We compute a composite regime score from 6 components: VIX (sub-20 = 0 = bullish), SPX breadth (above 50/200 DMA), Credit (HYG spread normalization), DXY (weak dollar = bullish for multinationals), Liquidity (Fed balance sheet trend), and TLT (bond market signal). Score range 0–1: 0–0.30 = RISK-ON, 0.30–0.50 = NEUTRAL/Early Risk-Off, 0.50–0.70 = RISK-OFF, >0.70 = DEEP RISK-OFF. The VIX close behavior is the primary confirmation signal.

2. Multi-Strategy Screening

We run 3 complementary DSL screens: (a) Momentum Expansion: close>sma(close,20) && vol>sma(vol,20)*1.5 && rsi14>50 && rsi14<75, (b) Breakout Squeeze: close>sma(close,50) && atr(14)>atr(28)*1.2, (c) Pullback-to-Support: rsi14<45 && close>sma(close,200) && close<sma(close,50)*1.05. Screened universe: US mega-caps, EU/ADR large-caps, Asian ADRs, and sector ETFs. Short Squeeze is excluded from all screens per protocol established March 20, 2026.

3. Composite Scoring (4 Factors)

Each setup receives a score 0–100 based on: Technical (40%) — RSI position, MACD signal, SMA alignment, volume vs average; Momentum (30%) — 1-week, 1-month, 3-month price performance; Confluence (20%) — number of independent signals aligned (min 3 required for A+); Catalyst (10%) — identifiable near-term catalyst (earnings, sector rotation, macro event). Only setups scoring ≥85 qualify as A+.

4. Anti-Dilution & Quality Filter

All selected tickers are vetted for dilution risk: no S-3 shelf registrations, ATM programs, PIPE structures, or aggressive underwriter relationships. Short Squeeze permanently excluded. Open-position exclusions applied per current portfolio state.

5. Validation & Ranking

Final ranking prioritizes: (1) earnings catalyst recency/quality, (2) geopolitical/macro thematic alignment, (3) momentum quality, (4) diversification requirements (min 5 US, 2 EU, 1 Asia, 2 ETF). R/R minimum of 1:1.5 enforced for all setups. Sharia compliance tagged on every setup.

Data Sources

  • Price data: Yahoo Finance (via DailyTickers Gateway)
  • Market regime: DailyTickers RunAutoScreener (6-component model)
  • Screening: RunScreener DSL (3 strategies: momentum, breakout, pullback)
  • Fundamental data: MCP QueryData (quote, social_sentiment, capital_flow, insider_transactions)
  • Generated: Friday, June 26, 2026

Disclaimer

This scanner is for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security.

All setups carry risk. Past performance of the DailyTickers scanner does not guarantee future results. Entry zones, stops, and targets are estimates based on technical analysis and are not guarantees of execution. Market conditions can change rapidly.

DailyTickers is not a registered investment advisor. All content is provided “as is” without warranty of any kind. Always consult a qualified financial advisor before making investment decisions.

© 2026 DailyTickers — https://articles.dailytickers.com/scanner/20260626/

Régime Vue d'Ensemble Synthèse Performance Méthodologie Disclaimer